2023-12-192025-03-312025-03-31false15361911NORTH ISLINGTON ONE LIMITED2025-09-05falseiso4217:GBPxbrli:pure153619112023-12-18153619112025-03-31153619112023-12-192025-03-31153619112023-12-17153619112023-12-18153619112023-12-182023-12-1815361911bus:SmallEntities2023-12-192025-03-3115361911bus:AuditExempt-NoAccountantsReport2023-12-192025-03-3115361911bus:FullAccounts2023-12-192025-03-3115361911bus:PrivateLimitedCompanyLtd2023-12-192025-03-3115361911core:WithinOneYear2025-03-3115361911core:AfterOneYear2025-03-3115361911core:WithinOneYear2023-12-1815361911core:AfterOneYear2023-12-1815361911core:ShareCapital2025-03-3115361911core:SharePremium2025-03-3115361911core:RevaluationReserve2025-03-3115361911core:OtherReservesSubtotal2025-03-3115361911core:RetainedEarningsAccumulatedLosses2025-03-3115361911core:ShareCapital2023-12-1815361911core:SharePremium2023-12-1815361911core:RevaluationReserve2023-12-1815361911core:OtherReservesSubtotal2023-12-1815361911core:RetainedEarningsAccumulatedLosses2023-12-1815361911core:LandBuildings2025-03-3115361911core:PlantMachinery2025-03-3115361911core:Vehicles2025-03-3115361911core:FurnitureFittings2025-03-3115361911core:OfficeEquipment2025-03-3115361911core:NetGoodwill2025-03-3115361911core:IntangibleAssetsOtherThanGoodwill2025-03-3115361911core:ListedExchangeTraded2025-03-3115361911core:UnlistedNon-exchangeTraded2025-03-3115361911core:LandBuildings2023-12-1815361911core:PlantMachinery2023-12-1815361911core:Vehicles2023-12-1815361911core:FurnitureFittings2023-12-1815361911core:OfficeEquipment2023-12-1815361911core:NetGoodwill2023-12-1815361911core:IntangibleAssetsOtherThanGoodwill2023-12-1815361911core:ListedExchangeTraded2023-12-1815361911core:UnlistedNon-exchangeTraded2023-12-1815361911core:LandBuildings2023-12-192025-03-3115361911core:PlantMachinery2023-12-192025-03-3115361911core:Vehicles2023-12-192025-03-3115361911core:FurnitureFittings2023-12-192025-03-3115361911core:OfficeEquipment2023-12-192025-03-3115361911core:NetGoodwill2023-12-192025-03-3115361911core:IntangibleAssetsOtherThanGoodwill2023-12-192025-03-3115361911core:ListedExchangeTraded2023-12-192025-03-3115361911core:UnlistedNon-exchangeTraded2023-12-192025-03-3115361911core:MoreThanFiveYears2023-12-192025-03-3115361911core:Non-currentFinancialInstruments2025-03-3115361911core:Non-currentFinancialInstruments2023-12-1815361911dpl:CostSales2023-12-192025-03-3115361911dpl:DistributionCosts2023-12-192025-03-3115361911core:LandBuildings2023-12-192025-03-3115361911core:PlantMachinery2023-12-192025-03-3115361911core:Vehicles2023-12-192025-03-3115361911core:FurnitureFittings2023-12-192025-03-3115361911core:OfficeEquipment2023-12-192025-03-3115361911dpl:AdministrativeExpenses2023-12-192025-03-3115361911core:NetGoodwill2023-12-192025-03-3115361911core:IntangibleAssetsOtherThanGoodwill2023-12-192025-03-3115361911dpl:GroupUndertakings2023-12-192025-03-3115361911dpl:ParticipatingInterests2023-12-192025-03-3115361911dpl:GroupUndertakingscore:ListedExchangeTraded2023-12-192025-03-3115361911core:ListedExchangeTraded2023-12-192025-03-3115361911dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-12-192025-03-3115361911core:UnlistedNon-exchangeTraded2023-12-192025-03-3115361911dpl:CostSales2023-12-182023-12-1815361911dpl:DistributionCosts2023-12-182023-12-1815361911core:LandBuildings2023-12-182023-12-1815361911core:PlantMachinery2023-12-182023-12-1815361911core:Vehicles2023-12-182023-12-1815361911core:FurnitureFittings2023-12-182023-12-1815361911core:OfficeEquipment2023-12-182023-12-1815361911dpl:AdministrativeExpenses2023-12-182023-12-1815361911core:NetGoodwill2023-12-182023-12-1815361911core:IntangibleAssetsOtherThanGoodwill2023-12-182023-12-1815361911dpl:GroupUndertakings2023-12-182023-12-1815361911dpl:ParticipatingInterests2023-12-182023-12-1815361911dpl:GroupUndertakingscore:ListedExchangeTraded2023-12-182023-12-1815361911core:ListedExchangeTraded2023-12-182023-12-1815361911dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-12-182023-12-1815361911core:UnlistedNon-exchangeTraded2023-12-182023-12-1815361911core:NetGoodwill2025-03-3115361911core:IntangibleAssetsOtherThanGoodwill2025-03-3115361911core:LandBuildings2025-03-3115361911core:PlantMachinery2025-03-3115361911core:Vehicles2025-03-3115361911core:FurnitureFittings2025-03-3115361911core:OfficeEquipment2025-03-3115361911core:AfterOneYear2025-03-3115361911core:WithinOneYear2025-03-3115361911core:ListedExchangeTraded2025-03-3115361911core:UnlistedNon-exchangeTraded2025-03-3115361911core:ShareCapital2025-03-3115361911core:SharePremium2025-03-3115361911core:RevaluationReserve2025-03-3115361911core:OtherReservesSubtotal2025-03-3115361911core:RetainedEarningsAccumulatedLosses2025-03-3115361911core:NetGoodwill2023-12-1815361911core:IntangibleAssetsOtherThanGoodwill2023-12-1815361911core:LandBuildings2023-12-1815361911core:PlantMachinery2023-12-1815361911core:Vehicles2023-12-1815361911core:FurnitureFittings2023-12-1815361911core:OfficeEquipment2023-12-1815361911core:AfterOneYear2023-12-1815361911core:WithinOneYear2023-12-1815361911core:ListedExchangeTraded2023-12-1815361911core:UnlistedNon-exchangeTraded2023-12-1815361911core:ShareCapital2023-12-1815361911core:SharePremium2023-12-1815361911core:RevaluationReserve2023-12-1815361911core:OtherReservesSubtotal2023-12-1815361911core:RetainedEarningsAccumulatedLosses2023-12-1815361911core:NetGoodwill2023-12-1715361911core:IntangibleAssetsOtherThanGoodwill2023-12-1715361911core:LandBuildings2023-12-1715361911core:PlantMachinery2023-12-1715361911core:Vehicles2023-12-1715361911core:FurnitureFittings2023-12-1715361911core:OfficeEquipment2023-12-1715361911core:AfterOneYear2023-12-1715361911core:WithinOneYear2023-12-1715361911core:ListedExchangeTraded2023-12-1715361911core:UnlistedNon-exchangeTraded2023-12-1715361911core:ShareCapital2023-12-1715361911core:SharePremium2023-12-1715361911core:RevaluationReserve2023-12-1715361911core:OtherReservesSubtotal2023-12-1715361911core:RetainedEarningsAccumulatedLosses2023-12-1715361911core:AfterOneYear2023-12-192025-03-3115361911core:WithinOneYear2023-12-192025-03-3115361911core:Non-currentFinancialInstrumentscore:CostValuation2023-12-192025-03-3115361911core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-12-192025-03-3115361911core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-12-192025-03-3115361911core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-12-192025-03-3115361911core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-12-192025-03-3115361911core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-12-192025-03-3115361911core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-12-192025-03-3115361911core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-12-192025-03-3115361911core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-12-192025-03-3115361911core:Non-currentFinancialInstrumentscore:CostValuation2025-03-3115361911core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-03-3115361911core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-03-3115361911core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-03-3115361911core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-03-3115361911core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-03-3115361911core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-03-3115361911core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-03-3115361911core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-03-3115361911core:Non-currentFinancialInstrumentscore:CostValuation2023-12-1815361911core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-12-1815361911core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-12-1815361911core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-12-1815361911core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-12-1815361911core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-12-1815361911core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-12-1815361911core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-12-1815361911core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-12-1815361911bus:Director12023-12-192025-03-3115361911bus:Director22023-12-192025-03-3115361911bus:Director32023-12-192025-03-31

NORTH ISLINGTON ONE LIMITED

Registered Number
15361911
(England and Wales)

Unaudited Financial Statements for the Period ended
31 March 2025

NORTH ISLINGTON ONE LIMITED
Company Information
for the period from 19 December 2023 to 31 March 2025

Directors

BOWRY, Neelesh, Dr
HOWELL, Robert, Dr
MCINTYRE, Sabrina, Dr

Registered Address

96 St. John's Way
London
N19 3RN

Registered Number

15361911 (England and Wales)
NORTH ISLINGTON ONE LIMITED
Balance Sheet as at
31 March 2025

Notes

2025

£

£

Current assets
Debtors3163,654
Cash at bank and on hand727,377
891,031
Creditors amounts falling due within one year4(891,027)
Net current assets (liabilities)4
Total assets less current liabilities4
Net assets4
Capital and reserves
Called up share capital3
Profit and loss account1
Shareholders' funds4
The financial statements were approved and authorised for issue by the Board of Directors on 5 September 2025, and are signed on its behalf by:
BOWRY, Neelesh, Dr
Director
Registered Company No. 15361911
NORTH ISLINGTON ONE LIMITED
Notes to the Financial Statements
for the period ended 31 March 2025

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Functional and presentation currency
The financial statements are presented in sterling and this is the functional currency of the company.
Going concern
After reviewing the company's forecasts and projections, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. The company therefore continues to adopt the going concern basis of accounting in preparing its financial statements.
Judgements and key sources of estimation uncertainty
In the application of the company's accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying values of assets and liabilities that are not readily apparent from other sources. These critical accounting judgements and estimations are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates. The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised if the revision affects only that period, or in the period of the revision and future periods if the revision affects both current and future periods. The critical judgements made by management that have a significant effect on the amounts recognised in the financial statements are described below.
Turnover policy
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services.
Revenue from rendering of services
Revenue from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs. Turnover is only recognised to the extent of recoverable expenses when the outcome of a contract cannot be estimated reliably.
Interest income
Interest income is recognised using the effective interest rate method.
Employee benefits
Short-term employee benefits are measured at the undiscounted amount expected to be paid in exchange for the employee's services to the company. Where employees have accrued short-term benefits which the entity has not paid by the balance sheet date, an accrual is recognised within creditors: amounts falling due within one year together with an associated expense in profit or loss. The liabilities are classified as current obligations in the statement of financial position because they are expected to be settled wholly within twelve months after the end of the period.
Current taxation
Current tax is recognised in profit or loss, except for taxes related to revaluations of land and buildings which are recognised in other comprehensive income. Current tax represents the amount of tax payable (receivable) in respect of taxable profit (loss) for the current, or past, reporting periods. Current tax is measured at the amount expected to be paid (recovered) using the tax rates and laws which have been enacted, or substantively enacted, by the balance sheet date. Where payments to HM Revenue and Customs exceed liabilities owed, an asset is recognised to the extent of the amount of tax recoverable.
Trade and other debtors
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.
Cash and cash equivalents
Cash and cash equivalents comprise cash at bank and on hand, demand deposits with banks and other short-term highly liquid investments with original maturities of three months or less. Bank overdrafts are disclosed separately. For the purpose of the cash flow statement, bank overdrafts form an integral part of the company's cash management and are included as a component of cash and cash equivalents.
Trade and other creditors
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
Financial instruments
A financial asset or a financial liability is recognised only when the entity becomes a party to the contractual provisions of the instrument. Basic financial instruments are initially recognised at transaction price and measured at amortised cost using the effective interest method. Where investments in non-derivative financial instruments are publicly traded, or their fair value can otherwise be measured reliably, the investment is subsequently measured at fair value through profit and loss. All other investments are subsequently measured at cost less impairment. Financial assets which are measured at cost or amortised cost are reviewed for objective evidence of impairment at each balance sheet date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss immediately. All equity instruments, regardless of significance, and other financial assets that are individually significant, are assessed individually for impairment.
2.Average number of employees

2025
Average number of employees during the year8
3.Debtors: amounts due within one year

2025

£
Prepayments and accrued income163,654
Total163,654
4.Creditors: amounts due within one year

2025

£
Trade creditors / trade payables332,558
Other creditors295,036
Accrued liabilities and deferred income263,433
Total891,027
5.Change in reporting period and impact on comparability
These financial statements cover the period from 19 December 2023 to 31 March 2025, which is 15 months in length. This extended period reflects the company’s first accounting period since incorporation.